T1	Participants 53 119	cancer patients treated with autologous stem cell transplantation:
T2	Participants 313 378	cancer patients treated with autologous stem cell transplantation
T3	Participants 692 722	whereas extended care patients
T4	Participants 1015 1294	RESULTS Thirty-seven patients consented to participate in the study (54% male; mean age 58.7 ± 9.5 years; median body mass index 26.8 kg m(-2) , range 16.4-47.6 kg m(-2) ); 33 patients completed the study and 28 patients returned the questionnaire (response rate = 85%)
T5	Participants 1669 1690	difference = 0.56).
T6	Participants 1691 1752	CONCLUSIONS Cancer patients treated with autologous stem cell
T7	Participants 1799 1823	extended nutrition care.
T8	Participants 1824 1832	Extended
